{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "10517752", "DateCompleted": {"Year": "1999", "Month": "11", "Day": "17"}, "DateRevised": {"Year": "2017", "Month": "12", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "8750-7587", "JournalIssue": {"Volume": "87", "Issue": "4", "PubDate": {"Year": "1999", "Month": "Oct"}}, "Title": "Journal of applied physiology (Bethesda, Md. : 1985)", "ISOAbbreviation": "J Appl Physiol (1985)"}, "ArticleTitle": "Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein.", "Pagination": {"StartPage": "1272", "EndPage": "1278", "MedlinePgn": "1272-8"}, "Abstract": {"AbstractText": ["Control of airway smooth muscle is provided by parasympathetic nerves that release acetylcholine onto M(3) muscarinic receptors. Acetylcholine release is limited by inhibitory M(2) muscarinic receptors. In antigen-challenged guinea pigs, hyperresponsiveness is due to blockade of neuronal M(2) receptors by eosinophil major basic protein (MBP). Because exposure of guinea pigs to ozone also causes M(2) dysfunction and airway hyperresponsiveness, the role of eosinophils in ozone-induced hyperresponsiveness was tested. Animals were exposed to filtered air or to 2 parts/million ozone for 4 h. Twenty-four hours later, the muscarinic agonist pilocarpine no longer inhibited vagally induced bronchoconstriction in ozone-exposed animals, indicating M(2) dysfunction. M(2) receptor function in ozone-exposed animals was protected by depletion of eosinophils with antibody to interleukin-5 and by pretreatment with antibody to guinea pig MBP. M(2) function was acutely restored by removal of MBP with heparin. Ozone-induced hyperreactivity was also prevented by antibody to MBP and was reversed by heparin. These data show that loss of neuronal M(2) receptor function after ozone is due to release of eosinophil MBP."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Health Sciences, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA."}], "Identifier": [], "LastName": "Yost", "ForeName": "B L", "Initials": "BL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Gleich", "ForeName": "G J", "Initials": "GJ"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fryer", "ForeName": "A D", "Initials": "AD"}], "GrantList": [{"GrantID": "ES-03819", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "HL-55543", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-61013", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Appl Physiol (1985)", "NlmUniqueID": "8502536", "ISSNLinking": "0161-7567"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antibodies"}, {"RegistryNumber": "0", "NameOfSubstance": "Blood Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Eosinophil Granule Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-5"}, {"RegistryNumber": "0", "NameOfSubstance": "Muscarinic Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Muscarinic Antagonists"}, {"RegistryNumber": "01MI4Q9DI3", "NameOfSubstance": "Pilocarpine"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 3.1.-", "NameOfSubstance": "Ribonucleases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antibodies"}, {"QualifierName": ["immunology", "pharmacology"], "DescriptorName": "Blood Proteins"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bronchoconstriction"}, {"QualifierName": [], "DescriptorName": "Electric Stimulation"}, {"QualifierName": [], "DescriptorName": "Eosinophil Granule Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Eosinophils"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": ["immunology"], "DescriptorName": "Interleukin-5"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Muscarinic Agonists"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Muscarinic Antagonists"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pilocarpine"}, {"QualifierName": [], "DescriptorName": "Ribonucleases"}, {"QualifierName": ["physiology"], "DescriptorName": "Vagus Nerve"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "10", "Day": "12"}, {"Year": "1999", "Month": "10", "Day": "12", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "10", "Day": "12", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10517752", "10.1152/jappl.1999.87.4.1272"]}}], "PubmedBookArticle": []}